Home/Pipeline/PROST Trial

PROST Trial

Ischemic Stroke (Thrombectomy)

Clinical TrialActive

Key Facts

Indication
Ischemic Stroke (Thrombectomy)
Phase
Clinical Trial
Status
Active
Company

About Phenox

Phenox is a privately held, commercial-stage medical device company specializing in interventional neurology. It has established a robust portfolio of products for ischemic stroke (thrombectomy) and hemorrhagic stroke (aneurysm treatment), with a strong focus on evidence-based medicine through rigorous clinical trials like COATING and PROST. The company is actively expanding its global commercial footprint and continues to innovate within the high-growth neurovascular market, positioning itself as a key player alongside larger medtech corporations.

View full company profile